Key Point: Patients with limited social support may be particularly susceptible to developing anxiety symptoms.
|
|
- Anna Fowler
- 7 years ago
- Views:
Transcription
1 CHAPTER 8: ANXIETY DISORDERS IN PATIENTS WITH HIV/AIDS Anxiety is a common symptom in HIV-infected patients. When anxiety symptoms are severe or persistent, patients may have an anxiety disorder. These disorders include panic disorder, generalized anxiety disorder, obsessive-compulsive disorder, and post-traumatic stress disorder (PTSD) (see Chapter 9: Trauma and Post-Traumatic Stress Disorder in Patients With HIV/AIDS). A recent study has shown that among HIV-infected patients receiving medical care, 20.3% have an anxiety disorder, with 12.3% meeting the criteria for panic disorder, 10.4% for PTSD, and 2.8% having generalized anxiety disorder. 1 Patients with other psychiatric disorders, such as adjustment disorders, major depression, psychosis, or substance use disorders, can also present with significant anxiety. To help patients receive optimal care, clinicians need to be aware of the differences among these specific disorders. Furthermore, patients with histories of anxiety or mood disorders are susceptible to recurrence of anxiety symptoms during the course of HIV illness. Key Point: Patients with limited social support may be particularly susceptible to developing anxiety symptoms. I. CLINICAL PRESENTATION RECOMMENDATION: Clinicians should consider the diagnosis of an anxiety disorder when a patient presents with common somatic symptoms, such as chest pain, diaphoresis, dizziness, gastrointestinal disturbances, and/or headache, for which no underlying medical etiology can be established. Anxiety can present with a wide range of physiological manifestations, such as shortness of breath, chest pain, racing/pounding heart, dizziness, diaphoresis, numbness or tingling, nausea, or the sensation of choking. When patients present with these somatic symptoms, for which no underlying medical etiology can be established, clinicians should consider an anxiety disorder as the cause. In addition to somatic complaints, patients with anxiety disorders often present with fear, worry, insomnia, impaired concentration and memory, diminished appetite, ruminations, compulsive rituals, and avoidance of situations that make them anxious. The following questions may help clinicians determine whether anxiety is present: Are you anxious? Are you fearful or afraid? Do you worry a lot? Are you tense or irritable? Are you restless? Do you have difficulty sleeping? 1
2 II. DIAGNOSIS A. Diagnosis Anxiety symptoms such as worry, nervousness, fear, and tension are commonly experienced by people with HIV during periods of their illness and may be a response to stressful situations. An anxiety disorder occurs when symptoms: Interfere with a patient s daily function (e.g., the patient is unable to work, leave home, attend to medical care) Interfere with personal relationships Cause marked subjective distress Even brief episodes of anxiety, such as those occurring during a panic attack, may interfere markedly in a patient s life and may warrant a diagnosis of an anxiety disorder. B. Differential Diagnosis 1. Mental Health Disorders and Medical Conditions RECOMMENDATIONS: Clinicians should exclude other mental health disorders in patients who present with anxiety. Clinicians should exclude medical conditions, including HIV-related central nervous system disease, in patients who present with anxiety. Clinicians should review medication regimens and substance use history in patients with anxiety. Anxiety-like symptoms may also be caused by mental health disorders other than anxiety disorders. For example, it may be difficult to distinguish depression with agitation from an adjustment disorder with anxious mood. In general, adjustment reactions follow a stressful event, which is often not true in clinical depression, and are less likely to present with the entire vegetative symptom complex seen in depression, which is characterized by insomnia, diminished appetite, diurnal variation in mood, loss of pleasure/interest, feelings of guilt, fatigue, and attention and concentration problems. Underlying medical conditions may also cause anxiety-like symptoms. Clinicians should exclude medical etiologies when evaluating patients who present with these symptoms. Patients can present with anxiety-like symptoms due to any one of the following conditions: CNS pathologies: HIV-related infections, neoplasms, dementia, or delirium Systemic or metabolic illness: hypoxia, sepsis, electrolyte imbalance Endocrinopathies: thyroid disease, hypoglycemia, pheochromocytoma, Cushing s syndrome Respiratory conditions: pneumonia Cardiovascular conditions: arrhythmias, pulmonary embolus Substance intoxication/withdrawal: from alcohol, nicotine, caffeine, cocaine, and amphetamines 2
3 In addition, psychotropic medications and other commonly prescribed medications may cause anxiety-like symptoms (see Table 1). Intoxication or withdrawal from substances such as alcohol, nicotine, caffeine, cocaine, and amphetamines can also cause anxiety. Table 1 Medications That May Cause Anxiety-Like Symptoms in HIV-Infected Patients Antihypertensives Category Reserpine Hydralazine Medication Antituberculous agents Psychotropics Sympathomimetics Isoniazid Cycloserine Most antipsychotic and antidepressant medications. Bupropion, an antidepressant that is also given for smoking cessation, makes some patients extremely anxious. Ephedrine Epinephrine Dopamine Phenylephrine Phenylpropanolamine Pseudoephedrine Antiretrovirals See the Adult HIV Guidelines, Chapter 4A: Antiretroviral Therapy, Appendix A Amphetamine and methylphenidate Digitalis Lidocaine Monosodium glutamate Nicotinic acid Procarbazine Steroids Theophylline and aminophylline Thyroid preparations 2. Anxiety Disorders Once an underlying medical etiology or substance/medication-induced cause has been excluded, a structured approach is helpful in distinguishing among the anxiety disorders (see Figure 1). 3
4 Anxious? Underlying medical, substance, or medication etiology? No Anxiety likely due to a general medical condition, substance, or medication Discrete episodes of intense anxiety/fear with chest pain, pounding heart, diaphoresis, shortness of breath? Fear/avoidance of certain situations, places, or objects? Worrying/ ruminating about a variety of things for months or years? Intrusive, disturbing thoughts or compulsive rituals? History of a traumatic event continuing to cause great distress? History of a stressful situation causing nervousness or upset? Panic attacks or panic disorder Phobias Generalized anxiety disorder Obsessivecompulsive disorder Event <1 month ago Symptoms >1 month Adjustment disorder with anxious mood Acute stress disorder PTSD Figure 1. Algorithm for distinguishing anxiety disorders. 4
5 III. MANAGEMENT OF HIV-INFECTED PATIENTS WITH ANXIETY DISORDERS RECOMMENDATION: Clinicians should refer patients with symptoms of anxiety to a psychiatrist for evaluation and possible ongoing treatment when: Anxiety symptoms do not respond to standard pharmlogic treatment or basic supportive/behavioral interventions The diagnosis of an anxiety disorder is difficult to establish Anxiety is persistent or severe Patients with obsessive-compulsive disorder have intrusive or disturbing thoughts or compulsive rituals that are poorly controlled with the current medication or that cause the patient marked subjective distress Anxiety occurs in patients with a significant substance use history or in those who are actively using substances A. Psychological/Supportive Intervention in the Primary Care Setting Certain anxiety symptoms can be effectively managed without the use of medication. There are also patients who prefer to avoid the use of psychotropic medication. Patients with mild anxiety symptoms that do not interfere with function may respond to supportive or behavioral interventions. Clinicians may find the following strategies helpful in such situations: Expressing empathy Educating patients about anxiety Reassuring patients that anxiety is the cause of somatic symptoms experienced during panic attacks Identifying the psychological factors that contribute to anxiety Preparing patients for stressful situations and assisting in development of coping mechanisms Teaching patients simple relaxation exercises. Slow, deep breathing with focus on inspiration and expiration of air can be helpful. Such exercises can be useful when patients practice for 1 minute three times a day, increasing to 5 minutes, if possible. Key Point: Basic supportive and behavioral interventions are sufficient to alleviate anxiety in certain patients. For patients with more severe anxiety, psychotherapy, specialized behavioral treatments such as cognitive-behavioral therapy, and/or medication may be required. 5
6 B. Pharmlogic Intervention in the Primary Care Setting RECOMMENDATION: Clinicians should be familiar with the safety profiles of medications used to treat anxiety and how these medications may interact with those used in the treatment of HIV disease (Appendix I). HIV-infected patients, especially those who are symptomatic, are more sensitive to medication side effects and may respond to lower dosages of anxiolytics. For these reasons, it is generally best to start low and go slow when prescribing medication. Furthermore, because patients are often receiving multiple medications, the potential for drug-drug interactions is great. Clinicians should be familiar with the safety profiles of medications used to treat anxiety and how these medications may interact with those used in the treatment of HIV disease (Appendix I). 1. General Principles in the Pharmlogic Treatment of Anxiety Disorders and Their Symptoms No single medication will treat the spectrum of symptoms seen in patients with anxiety disorders. The following general principles will help determine the pharmlogic intervention that is most likely to be helpful (see Table 2). Panic Attacks/Panic Disorder In general, while symptomatic relief for patients experiencing panic attacks can usually be accomplished with the short-term use of benzodiazepines, selective serotonin reuptake inhibitors (SSRIs) are the treatment of choice because they effectively prevent panic attacks from recurring. Given the morbidity associated with ongoing panic attacks, it is important to give prophylaxis to prevent recurrence. Venlafaxine is also effective in preventing panic attacks, as well as the tricyclic antidepressants, but the latter are limited in their usage due to their side-effect profiles and potential for drug-drug interactions. Generalized Anxiety Disorder Patients with chronic anxiety, consistent with generalized anxiety disorder, may require long-term therapy with medication. Buspirone should be considered because it is an effective anxiolytic that has no potential for abuse, which is particularly important for patients with a history of substance use. The SSRIs and venlafaxine can also be effective in some patients with persistent anxiety. Although some patients may experience relief sooner, the onset of action of buspirone (3-6 weeks) and SSRIs (2-4 weeks) may necessitate the shortterm use of benzodiazepines; however, these should be used with caution, because of the potential for dependence in some patients. Adjustment Disorder Short-term symptomatic relief may be helpful in some patients. A time-limited use (2-4 weeks) of benzodiazepines prescribed on a daily or as-needed basis can be effective. Post-Traumatic Stress Disorder See Chapter 9: Trauma and Post-Traumatic Stress Disorder in Patients With HIV/AIDS. Insomnia Insomnia is an important symptom to treat because it often causes impaired daily function. If an underlying medical etiology or chemical cause has been excluded, insomnia should almost always be considered a symptom of an underlying psychiatric disorder (major depression, adjustment disorder, generalized anxiety disorder, PTSD). Diagnosis and treatment of the underlying condition is essential and 6
7 often results in resolution of the insomnia. Nonpharmlogic approaches to treating insomnia should be tried before prescribing medications. See Chapter Somatic Symptoms for recommendations on treating insomnia. Table 2 Commonly Used Psychotropic Medications in the Treatment of Anxiety Disorders and Anxiety Symptoms Disorder or Symptom Panic disorder Medication or Medication Class SSRIs Citalopram Paroxetine Escitalopram Fluoxetine Sertraline Tricyclics Nortriptyline Doxepin Desipramine Imipramine Benzodiazepines Lorazepam Clonazepam Alprazolam Venlafaxine Generalized anxiety disorder Obsessive-compulsive disorder Adjustment disorder with anxious mood Insomnia* PTSD Major depression with significant anxiety Buspirone SSRIs (listed above) SSRIs (listed above) Fluvoxamine Venlafaxine Clomipramine Benzodiazepines (listed above) Zolpidem Benzodiazepines (listed above) and temazepam Trazodone Doxepin SSRIs (listed above) SSRIs (listed above) Benzodiazepines (listed above) Venlafaxine Tricyclics (listed above) * Nonpharmlogic approaches should be attempted before treatment with medication. See Chapter Somatic Symptoms. Sertraline and paroxetine are the only FDA-approved medications for PTSD. However, all SSRIs (in the same doses used for depression) are helpful in treating symptoms of depression and anxiety. See Chapter 9: Trauma and Post-Traumatic Stress Disorder in Patients With HIV/AIDS. See Chapter 6: Depression and Mania in Patients With HIV/AIDS. 7
8 2. Treatment of Anxiety Disorders in Substance Users RECOMMENDATIONS: Primary care clinicians should coordinate with a psychiatrist and/or addiction specialist when managing anxiety disorders among patients with substance use disorders. A psychiatric evaluation of these patients should be performed. Clinicians should discuss the long-term risks of dependence, withdrawal, and abuse, as well as the intended course of treatment, with patients with substance use disorders or a history of substance use disorders before benzodiazepines or other controlled substances are used to treat an anxiety disorder. Clinicians should make the decision to withhold benzodiazepines on a case-by-case basis, weighing the risks and benefits for patients with substance use disorders. The treatment of patients with anxiety who have a substance use history or who are actively using substances poses a challenge for clinicians. Such patients are most effectively managed when treatment is coordinated with a psychiatrist/addiction specialist. Psychiatric evaluation should be recommended for such patients. In some cases, clinicians should defer initiating treatment until the evaluation is completed. Although most clinicians attempt to avoid the use of medications with potential for abuse, such as benzodiazepines and other controlled substances, such treatment is indicated in some clinical situations. In these cases, discussions about the long-term risks of dependence, withdrawal, and abuse and the intended course of treatment are necessary prior to initiation of medication. The decision to withhold benzodiazepines should be made on a case-by-case basis, weighing the risks and benefits. Furthermore, the risk of discontinuing or withholding benzodiazepines may have serious medical complications. Documentation in the medical record of the decision-making process is essential to ensure consistency and continuity of care. (See Chapter Substance Use and Mental Health in HIV-Infected Patients.) REFERENCE 1. Vitiello B, Burnam MA, Bing EG, et al. Use of psychotropic medications among HIV-infected patients in the United States. Am J Psychiatry 2003;160:
Anxiety, Panic and Other Disorders
Methodist Assistance Program Anxiety, Panic and Other Disorders Anxiety, panic and other disorders such as agoraphobia, social phobia, compulsive disorder and posttraumatic stress disorder are all very
More informationPostpartum Depression and Post-Traumatic Stress Disorder
Postpartum Depression and Post-Traumatic Stress Disorder Emotional Recovery: Postpartum Depression and Post-Traumatic Stress Disorder By: Lisa Houchins Published: July 23, 2013 Emotions vary widely after
More informationCOUNTY OF LOS ANGELES - DEPARTMENT OF MENTAL HEALTH OFFICE OF THE MEDICAL DIRECTOR. 3.4 PARAMETERS FOR THE USE OF ANXIOLYTIC MEDICATIONS October 2014
COUNTY OF LOS ANGELES - DEPARTMENT OF MENTAL HEALTH OFFICE OF THE MEDICAL DIRECTOR 3.4 PARAMETERS FOR THE USE OF ANXIOLYTIC MEDICATIONS October 2014 I. GENERAL CONSIDERATIONS A. Definition: Anxiolytic
More informationTREATING MAJOR DEPRESSIVE DISORDER
TREATING MAJOR DEPRESSIVE DISORDER A Quick Reference Guide Based on Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Second Edition, originally published in April 2000.
More informationRecognition and Treatment of Depression in Parkinson s Disease
Recognition and Treatment of Depression in Parkinson s Disease Web Ross VA Pacific Islands Health Care System What is depression? Depression is a serious medical condition that affects a person s feelings,
More informationMajor Depression. What is major depression?
Major Depression What is major depression? Major depression is a serious medical illness affecting 9.9 million American adults, or approximately 5 percent of the adult population in a given year. Unlike
More informationAnxiety Disorders in the Elderly
Janel Gauthier, Ph. D. Among older people (65 years of age and older), many worry about their health, family, financial situation and mortality. These worries are even more likely to arise when they feel
More information`çããçå=jéåí~ä= aáëçêçéêëw=^åñáéíó=~åç= aééêéëëáçå. aêk=`=f=lâçåü~ jéçáå~ä=aáêéåíçê lñäé~ë=kep=cçìåç~íáçå=qêìëí=
`çããçå=jéåí~ä= aáëçêçéêëw=^åñáéíó=~åç= aééêéëëáçå aêk=`=f=lâçåü~ jéçáå~ä=aáêéåíçê lñäé~ë=kep=cçìåç~íáçå=qêìëí= Overview: Common Mental What are they? Disorders Why are they important? How do they affect
More informationDepression Flow Chart
Depression Flow Chart SCREEN FOR DEPRESSION ANNUALLY Assess for depression annually with the PHQ-9. Maintain a high index of suspicion in high risk older adults. Consider suicide risk and contributing
More informationBRIEF NOTES ON THE MENTAL HEALTH OF CHILDREN AND ADOLESCENTS
BRIEF NOTES ON THE MENTAL HEALTH OF CHILDREN AND ADOLESCENTS The future of our country depends on the mental health and strength of our young people. However, many children have mental health problems
More informationMental health issues in the elderly. January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca
Mental health issues in the elderly January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca Cognitive Disorders Outline Dementia (294.xx) Dementia of the Alzheimer's Type (early and late
More informationIMR ISSUES, DECISIONS AND RATIONALES The Final Determination was based on decisions for the disputed items/services set forth below:
Case Number: CM13-0018009 Date Assigned: 10/11/2013 Date of Injury: 06/11/2004 Decision Date: 01/13/2014 UR Denial Date: 08/16/2013 Priority: Standard Application Received: 08/29/2013 HOW THE IMR FINAL
More informationGeneralised anxiety disorder in adults
www.bpac.org.nz keyword: anxiety Generalised anxiety disorder in adults diagnosis and management Key concepts: Anxiety disorders are the most frequently seen mental disorders in primary care Generalised
More informationDepression is a common biological brain disorder and occurs in 7-12% of all individuals over
Depression is a common biological brain disorder and occurs in 7-12% of all individuals over the age of 65. Specific groups have a much higher rate of depression including the seriously medically ill (20-40%),
More informationANXIETY DISORDERS. TASK: Recognize warning signs and symptoms of Anxiety Disorders.
TASK: Recognize warning signs and symptoms of Anxiety Disorders. STANDARDS: Soldiers will understand how recognize signs of anxiety and better assist others when one may be having symptoms or showing signs
More informationTREATMENT-RESISTANT DEPRESSION AND ANXIETY
University of Washington 2012 TREATMENT-RESISTANT DEPRESSION AND ANXIETY Catherine Howe, MD, PhD University of Washington School of Medicine Definition of treatment resistance Failure to remit after 2
More informationWhat are the best treatments?
What are the best treatments? Description of Condition Depression is a common medical condition with a lifetime prevalence in the United States of 15% among adults. Symptoms include feelings of sadness,
More informationNorth Pacific Epilepsy Research 2311 NW Northrup Street Suite #202 Portland, Oregon 97210 Tel: 503-291-5300 Fax: 503-291-5303
North Pacific Epilepsy Research 2311 NW Northrup Street Suite #202 Portland, Oregon 97210 Tel: 503-291-5300 Fax: 503-291-5303 Post-Traumatic Stress Disorder (PTSD) Post-traumatic stress disorder (PTSD)
More informationDepre r s e sio i n o i n i a dults Yousuf Al Farsi
Depression in adults Yousuf Al Farsi Objectives 1. Aetiology 2. Classification 3. Major depression 4. Screening 5. Differential diagnosis 6. Treatment approach 7. When to refer 8. Complication 9. Prognosis
More informationPsychopharmacotherapy for Children and Adolescents
TREATMENT GUIDELINES Psychopharmacotherapy for Children and Adolescents Guideline 7 Psychopharmacotherapy for Children and Adolescents Description There are few controlled trials to guide practitioners
More informationElizabeth A. Crocco, MD Assistant Clinical Professor Chief, Division of Geriatric Psychiatry Department of Psychiatry and Behavioral Sciences Miller
Elizabeth A. Crocco, MD Assistant Clinical Professor Chief, Division of Geriatric Psychiatry Department of Psychiatry and Behavioral Sciences Miller School of Medicine/University of Miami Question 1 You
More informationPOST-TRAUMATIC STRESS DISORDER PTSD Diagnostic Criteria PTSD Detection and Diagnosis PC-PTSD Screen PCL-C Screen PTSD Treatment Treatment Algorithm
E-Resource March, 2014 POST-TRAUMATIC STRESS DISORDER PTSD Diagnostic Criteria PTSD Detection and Diagnosis PC-PTSD Screen PCL-C Screen PTSD Treatment Treatment Algorithm Post-traumatic Stress Disorder
More informationand body dysmorphic disorder (BDD) in adults, children and young people Issue date: November 2005
Issue date: November 2005 Treating obsessivecompulsive disorder (OCD) and body dysmorphic disorder (BDD) in adults, children and young people Understanding NICE guidance information for people with OCD
More informationTraumatic Stress. and Substance Use Problems
Traumatic Stress and Substance Use Problems The relation between substance use and trauma Research demonstrates a strong link between exposure to traumatic events and substance use problems. Many people
More informationDepression and Anxiety in Parkinson s disease
Depression and Anxiety in Parkinson s disease Greg Pontone, MD Director, Movement Disorders Psychiatry Clinical Programs at Johns Hopkins Morris K. Udall Parkinson's Disease Research Center Johns Hopkins
More informationDepression in the Elderly: Recognition, Diagnosis, and Treatment
Depression in the Elderly: Recognition, Diagnosis, and Treatment LOUIS A. CANCELLARO, PhD, MD, EFAC Psych Professor Emeritus and Interim Chair ETSU Department of Psychiatry & Behavioral Sciences Diagnosis
More informationCare Manager Resources: Common Questions & Answers about Treatments for Depression
Care Manager Resources: Common Questions & Answers about Treatments for Depression Questions about Medications 1. How do antidepressants work? Antidepressants help restore the correct balance of certain
More informationDepression Assessment & Treatment
Depressive Symptoms? Administer depression screening tool: PSC Depression Assessment & Treatment Yes Positive screen Safety Screen (see Appendix): Administer every visit Neglect/Abuse? Thoughts of hurting
More informationClinical guideline Published: 29 November 2005 nice.org.uk/guidance/cg31
Obsessive-compulsive e disorder and body dysmorphic disorder: treatment Clinical guideline Published: 29 November 2005 nice.org.uk/guidance/cg31 NICE 2005. All rights reserved. Contents Introduction...
More informationMOH CLINICAL PRACTICE GUIDELINES 6/2011 DEPRESSION
MOH CLINICAL PRACTICE GUIDELINES 6/2011 DEPRESSION Executive summary of recommendations Details of recommendations can be found in the main text at the pages indicated. Clinical evaluation D The basic
More informationNICE Clinical guideline 23
NICE Clinical guideline 23 Depression Management of depression in primary and secondary care Consultation on amendments to recommendations concerning venlafaxine On 31 May 2006 the MHRA issued revised
More information309.28 F43.22 Adjustment disorder with mixed anxiety and depressed mood Adjustment disorder with disturbance of conduct
Description ICD-9-CM Code ICD-10-CM Code Adjustment reaction with adjustment disorder with depressed mood 309.0 F43.21 Adjustment disorder with depressed mood Adjustment disorder with anxiety 309.24 F43.22
More informationClinical Practice Guideline: Depression in Primary Care, Adult 4 Taft Court Rockville, MD 20850 www.mamsi.com
Clinical Practice Guideline: Depression in 4 Taft Court Rockville, MD 20850 www.mamsi.com 40 05 17 035 3/03 Once a primary care patient presents with depressive symptoms, the primary care physician makes
More informationPSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS. Juanaelena Garcia, MD Psychiatry Director Institute for Family Health
PSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS Juanaelena Garcia, MD Psychiatry Director Institute for Family Health Learning Objectives Learn basics about the various types of medications that
More informationDisclosures Christer Allgulander
How Patients With Generalized Anxiety Disorder (GAD) Are Treated in Specialized Care: A Pharmacoepidemiological Case Register Study in Sweden Christer Allgulander MD, Karolinska Institutet, Sweden Jan
More informationDepression in Older Persons
Depression in Older Persons How common is depression in later life? Depression affects more than 6.5 million of the 35 million Americans aged 65 or older. Most people in this stage of life with depression
More informationDEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource
E-Resource March, 2015 DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource Depression affects approximately 20% of the general population
More informationCO-OCCURRING DISORDERS. Michaelene Spence MA LADC 8/8/12
CO-OCCURRING DISORDERS Michaelene Spence MA LADC 8/8/12 Activity Chemical Health? Mental Health? Video- What is Addiction HBO Terminology MI/CD: Mental Illness/Chemical Dependency IDDT: Integrated Dual
More informationMAJOR DEPRESSION DURING CONCEPTION AND PREGNANCY: A Guide for Patients and Families
MAJOR DEPRESSION DURING CONCEPTION AND PREGNANCY: A Guide for Patients and Families David A. Kahn, MD, Margaret L. Moline, PhD, Ruth W. Ross, MA, Lee S. Cohen, MD, and Lori L. Altshuler, MD www.womensmentalhealth.org
More informationFeeling Moody? Major Depressive. Disorder. Is it just a bad mood or is it a disorder? Mood Disorders. www.seclairer.com S Eclairer 724-468-3999
Feeling Moody? Is it just a bad mood or is it a disorder? Major Depressive Disorder Prevalence: 7%; 18-29 years old; Female>Male DDx: Manic episodes with irritable mood or mixed episodes, mood disorder
More informationPrescribing and Tapering Benzodiazepines
E-Resource October, 2014 Prescribing and Tapering Benzodiazepines The use of benzodiazepines has grown over time and evidence has shown that long term use of these drugs has very little benefit with many
More informationTreatment Bulletin. Anxiety, Depression & HIV. Toronto People With AIDS Foundation
Toronto People With AIDS Foundation Treatment Bulletin Anxiety, Depression & HIV January 2010 No. 1 Disclaimer Permission to Reproduce The Treatment Resources Program at the Toronto People With AIDS Foundation
More informationQuestions & Answers About OCD In Children and Adolescents
Questions & Answers About OCD In Children and Adolescents What is Obsessive Compulsive Disorder? Obsessive Compulsive Disorder (OCD) i s one o f the m ost comm on psychiatric illnesses affecting young
More informationDepression in Long-Term Care
Depression in Long-Term Care Annette Carron, DO, CMD, FACOI, FAAHPM Director Geriatrics and Palliative Care Botsford Hospital Slide 1 OBJECTIVES Know and understand: Incidence and morbidity of depressive
More informationPrimary Care Guide For Prescription Of Anxiolytic Medications For Persons With Mental Retardation and Developmental Disabilities (MR/DD)
Primary Care Guide For Prescription Of Anxiolytic Medications For Persons With Mental Retardation and Developmental Disabilities (MR/DD) Overview of Prescription The DD/MR patient may develop symptoms
More informationPOPULAR DEPRESSION MEDICATIONS
Popular Depression Medications A Helpful Guide to Antidepressant Drugs POPULAR DEPRESSION MEDICATIONS A Helpful Guide to Antidepressant Drugs Popular Depression Medications A Helpful Guide to Antidepressant
More informationElectroconvulsive Therapy - ECT
Electroconvulsive Therapy - ECT Introduction Electroconvulsive therapy, or ECT, is a safe and effective treatment that may reduce symptoms related to depression or mental illness. During ECT, certain parts
More informationFACT SHEET 4. Bipolar Disorder. What Is Bipolar Disorder?
FACT SHEET 4 What Is? Bipolar disorder, also known as manic depression, affects about 1 percent of the general population. Bipolar disorder is a psychiatric disorder that causes extreme mood swings that
More informationGlossary Of Terms Related To The Psychological Evaluation Pain
Glossary Of Terms Related To The Psychological Evaluation Pain Excerpted From The BHI 2 Manual By Daniel Bruns and John Mark Disorbio 2003 by Pearson Assessments. All rights reserved. Addiction: A chronic
More informationWhy are antidepressants used to treat IBS? Some medicines can have more than one action (benefit) in treating medical problems.
The Use of Antidepressants in the Treatment of Irritable Bowel Syndrome and Other Functional GI Disorders Christine B. Dalton, PA-C Douglas A. Drossman, MD What are functional GI disorders? There are more
More informationUpdate on guidelines on biological treatment of depressive disorder. Dr. Henry CHEUNG Psychiatrist in private practice
Update on guidelines on biological treatment of depressive disorder Dr. Henry CHEUNG Psychiatrist in private practice 2013 update International Task Force of World Federation of Societies of Biological
More informationAnxiety. Providing services we would be happy for our own families to use
Anxiety Providing services we would be happy for our own families to use An information guide for Anxiety This booklet aim to: Give you an understanding of Anxiety, it s causes and symptoms Provide information
More informationAsthma, anxiety & depression
Anxiety and are common in people with asthma. The good news is that there are effective treatments both for asthma and for anxiety and. With careful management, the symptoms of anxiety and can be treated
More informationDepression: What You Need to Know
Depression: What You Need to Know What is a Depressive Illness? A depressive illness is a whole-body illness, involving your body, mood, thoughts, and behavior. It affects the way you eat and sleep, the
More informationUnderstanding common
anx Anxious moments: iety Understanding common iety disorders AMY GUIP The most frequently occurring of all psychiatric disorders, anxiety disorders affect 23 million Americans, or 1 in 4. These disorders
More informationRecognizing and Treating Depression in Children and Adolescents.
Recognizing and Treating Depression in Children and Adolescents. KAREN KANDO, MD Division of Child and Adolescent Psychiatry Center for Neuroscience and Behavioral Medicine Phoenix Children s Hospital
More informationCHAPTER 5 MENTAL, BEHAVIOR AND NEURODEVELOPMENT DISORDERS (F01-F99) March 2014. 2014 MVP Health Care, Inc.
CHAPTER 5 MENTAL, BEHAVIOR AND NEURODEVELOPMENT DISORDERS (F01-F99) March 2014 2014 MVP Health Care, Inc. CHAPTER 5 CHAPTER SPECIFIC CATEGORY CODE BLOCKS F01-F09 Mental disorders due to known physiological
More informationBehavioral Health Best Practice Documentation
Behavioral Health Best Practice Documentation Click on the desired Diagnoses link or press Enter to view all information. Diagnoses: DSM-5 and ICD-10 Codes Major Depressive Disorder Bipolar Disorder Eating
More informationDepressive disorders among older residents in a Chinese rural community. Risk for Depression by Age and Sex. Risk for Depression by Age and Sex
Risk for Depression by Age and Sex Risk for Depression by Age and Sex Depressive disorders among older residents in a Chinese rural community. Liu CY, et al: Psychological Medicine 1997:27: 943-949 Male
More informationSLEEP DISTURBANCE AND PSYCHIATRIC DISORDERS
E-Resource December, 2013 SLEEP DISTURBANCE AND PSYCHIATRIC DISORDERS Between 10-18% of adults in the general population and up to 50% of adults in the primary care setting have difficulty sleeping. Sleep
More informationBENZODIAZEPINE CONSIDERATIONS IN WORKERS COMPENSATION: IMPLICATIONS FOR WORK DISABILITY AND CLAIM COSTS By: Michael Erdil MD, FACOEM
3 rd Quarter 2015 BENZODIAZEPINE CONSIDERATIONS IN WORKERS COMPENSATION: IMPLICATIONS FOR WORK DISABILITY AND CLAIM COSTS By: Michael Erdil MD, FACOEM Introduction Benzodiazepines, sometimes called "benzos",
More informationAnxiety and depression in men
Anxiety and depression in men Summary Anxiety and depression in men are common and treatable. Anxiety and depression are illnesses, not weaknesses, and effective treatments are available. Taking action
More informationBrief Review of Common Mental Illnesses and Treatment
Brief Review of Common Mental Illnesses and Treatment Presentations to the Joint Subcommittee to Study Mental Health Services in the 21st Century September 9, 2014 Jack Barber, M.D. Medical Director Virginia
More informationSee also www.thiswayup.org.au/clinic for an online treatment course.
Depression What is depression? Depression is one of the common human emotional states. It is common to experience feelings of sadness and tiredness in response to life events, such as losses or disappointments.
More informationSocial phobia following maprotiline: The first case report. Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran
Social phobia following maprotiline: The first case report Seyed Hamzeh Hosseini (MD) 1*, Ebraheim Salehifar (PharmD) 2 1* Associate professor of Psychiatry, Department of Psychiatry, Faculty of Medicine,
More informationDEPRESSION DURING THE TRANSITION TO MENOPAUSE: A Guide for Patients and Families
DEPRESSION DURING THE TRANSITION TO MENOPAUSE: A Guide for Patients and Families David A. Kahn, MD, Margaret L. Moline, PhD, Ruth W. Ross, MA, Lori L. Altshuler, MD, and Lee S. Cohen, MD www.womensmentalhealth.org
More informationAlcohol Withdrawal Recognition and Treatment
Alcohol Withdrawal Recognition and Treatment Thomas Meyer BS EMS, MICP SREMSC Page 1 Purpose As EMTs a mantle of responsibility is placed upon you to ensure the safety and well-being of those in your charge
More informationDEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE
1 DEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE ASSESSMENT/PROBLEM RECOGNITION 1. Did the staff and physician seek and document risk factors for depression and any history of depression? 2. Did staff
More informationEXHIBIT D, COVERED BEHAVIORAL HEALTH DIAGNOSES
EXHIBIT D, COVERED BEHAVIORAL HEALTH DIAGNOSES Part I- Mental Health Covered Diagnoses 295-298.9 295 Schizophrenic s (the following fifth-digit sub-classification is for use with category 295) 0 unspecified
More informationHow to Recognize Depression and Its Related Mood and Emotional Disorders
How to Recognize Depression and Its Related Mood and Emotional Disorders Dr. David H. Brendel Depression s Devastating Toll on the Individual Reduces or eliminates pleasure and jo Compromises and destroys
More informationEating Disorder Treatment Protocol
Eating Disorder Treatment Protocol All Team Members: Patient Self-Management Education & Support Eating Disorders are incredibly debilitating and are associated with significant medical and psychosocial
More informationPaxil/Paxil-CR (paroxetine)
Generic name: Paroxetine Available strengths: 10 mg, 20 mg, 30 mg, 40 mg tablets; 10 mg/5 ml oral suspension; 12.5 mg, 25 mg, 37.5 mg controlled-release tablets (Paxil-CR) Available in generic: Yes, except
More informationA Sierra Tucson Publication. An Introduction to Mood Disorders & Treatment Options
A Sierra Tucson Publication An Introduction to Mood Disorders & Treatment Options 0 Introduction The term mood disorder refers to a category that includes the following mental health issues: Anxiety Disorders
More informationOCD & Anxiety: Helen Blair Simpson, M.D., Ph.D.
OCD & Anxiety: Symptoms, Treatment, & How to Cope Helen Blair Simpson, M.D., Ph.D. Professor of Clinical Psychiatry, Columbia University Director of the Anxiety Disorders Clinic, New York State Psychiatric
More informationALCOHOL AND OTHER DRUG WITHDRAWAL: PRACTICE GUIDELINES
ALCOHOL AND OTHER DRUG WITHDRAWAL: PRACTICE GUIDELINES 2009 Pauline Kenny Amy Swan Lynda Berends Linda Jenner Barbara Hunter Janette Mugavin CHAPTER 12: BENZODIAZEPINE WITHDRAWAL 12 BENZODIAZEPINES These
More informationIdentification, treatment and support for individuals with Alcohol & Drug Addiction in the Community
Identification, treatment and support for individuals with Alcohol & Drug Addiction in the Community Dr David Jackson Clinic Medical Officer The Hobart Clinic Association Drugs In tonight s context, drugs
More informationDepression in Older Adults A Guide for Patients and Families
The Expert Consensus Guideline Series Depression in Older Adults A Guide for Patients and Families Reprinted from: Alexopoulos GS, Katz IR, Reynolds CF III, Carpenter D, and Docherty JP. The Expert Consensus
More informationSponsored by: 2013 NAMI Maryland Conference Baltimore, Maryland; Friday, October 18 th, 2013
Integrated System of Care Universal Dual Diagnosis Capabilities Principles of Empathy and Hope Motivational Interviewing Approach Stages of Change Model Design Solution Focused Strength Based Skill Building
More informationSex and Love Addiction
Sex and Love Addiction Yes, love and sex can be addictive and as destructive, at least socially, as compulsive substance use. The high hinges on physical or psychological arousal, and relationships can
More informationUnderstanding anxiety and depression
Understanding anxiety and depression www.beyondblue.org.au 1300 22 4636 Anxiety Over two million people in Australia experience anxiety each year. On average, one in three women and one in fve men will
More informationDEMENTIA EDUCATION & TRAINING PROGRAM
The pharmacological management of aggression in the nursing home requires careful assessment and methodical treatment to assure maximum safety for patients, nursing home residents and staff. Aggressive
More informationDepression. Depress EPRESSION. Depression
Depress EPRESSION Depression Depression DEPRESSION Most people feel depressed at times. Losing a loved one, getting fired from a job, going through a divorce, and other difficult situations can lead a
More informationPost-traumatic stress disorder (PTSD): the treatment of PTSD in adults and children
Post-traumatic stress disorder (PTSD): the treatment of PTSD in adults and children Understanding NICE guidance information for people with PTSD, their advocates and carers, and the public March 2005 Information
More informationClinical Guideline / Formulary Document Pharmacy Department Medicines Management Services
Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services DEPRESSION Pharmacological Treatment of Depression NICE guidelines suggest the following stepped care model also
More informationDepression & Multiple Sclerosis
Depression & Multiple Sclerosis Managing specific issues Aaron, diagnosed in 1995. The words depressed and depression are used so casually in everyday conversation that their meaning has become murky.
More informationOriginal Article: http://www.mayoclinic.com/health/post-traumatic-stress-disorder
1 of 11 6/29/2012 12:17 PM MayoClinic.com reprints This single copy is for your personal, noncommercial use only. For permission to reprint multiple copies or to order presentation-ready copies for distribution,
More informationA BRIEF OVERVIEW OF PSYCHOTROPIC MEDICATION USE FOR PERSONS WITH INTELLECTUAL DISABILITIES
INTRODUCTION A BRIEF OVERVIEW OF PSYCHOTROPIC MEDICATION USE FOR PERSONS WITH INTELLECTUAL DISABILITIES Individuals with intellectual disabilities are not uncommonly prescribed psychotropic medications.
More informationDepression Treatment Guide
Depression Treatment Guide DSM V Criteria for Major Depressive Disorders A. Five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous
More informationPost-traumatic stress disorder overview
Post-traumatic stress disorder overview A NICE pathway brings together all NICE guidance, quality standards and materials to support implementation on a specific topic area. The pathways are interactive
More informationDepression. Medicines To Help You
Medicines To Help You Depression Use this guide to help you talk to your doctor, pharmacist, or nurse about your medicines for depression. The guide lists all of the FDA-approved products now available
More informationBipolar Disorder. Mania is the word that describes the activated phase of bipolar disorder. The symptoms of mania may include:
Bipolar Disorder What is bipolar disorder? Bipolar disorder, or manic depression, is a medical illness that causes extreme shifts in mood, energy, and functioning. These changes may be subtle or dramatic
More informationRegistered Charity No. 5365
THE MULTIPLE SCLEROSIS SOCIETY OF IRELAND Dartmouth House, Grand Parade, Dublin 6. Telephone: (01) 269 4599. Fax: (01) 269 3746 MS Helpline: 1850 233 233 E-mail: mscontact@ms-society.ie www.ms-society.ie
More informationAssessment and Diagnosis of DSM-5 Substance-Related Disorders
Assessment and Diagnosis of DSM-5 Substance-Related Disorders Jason H. King, PhD (listed on p. 914 of DSM-5 as a Collaborative Investigator) j.king@lecutah.com or 801-404-8733 www.lecutah.com D I S C L
More informationOverview of Mental Health Medication Trends
America s State of Mind Report is a Medco Health Solutions, Inc. analysis examining trends in the utilization of mental health related medications among the insured population. The research reviewed prescription
More informationThese guidelines are intended to support General Practitioners in the care of their patients with dementia both in the community and in care homes.
This is a new guideline. These guidelines are intended to support General Practitioners in the care of their patients with dementia both in the community and in care homes. It incorporates NICE clinical
More informationAmphetamines Addiction
Introduction Amphetamines, which are classified as stimulants, work by using the dopamine reward system of the brain. When these drugs are used, the user s central nervous system is simulated which causes
More informationA Depression Education Toolkit
A Depression Education Toolkit Facts about Depression in Older Adults What is Depression? Depression is a medical illness. When sadness persists or interferes with everyday life, it may be depression.
More informationObsessive Compulsive Disorder: a pharmacological treatment approach
Obsessive Compulsive Disorder: a pharmacological treatment approach Professor Alasdair Vance Head, Academic Child Psychiatry Department of Paediatrics University of Melbourne Royal Children s Hospital
More informationDepression and anxiety
alzheimers.org.uk Depression and anxiety Depression and anxiety are common conditions that are frequently experienced by people with dementia and their carers. They are known as psychological conditions
More information